AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Women with a history of late pregnancy loss should be screened for mutations in the genes that code for the coagulation factors prothrombin and factor V Leiden, according to Italian researchers.
Women with a history of late pregnancy loss are three times more likely to carry such genetic mutations, the investigators said. Still, the jury is out on whether the benefits of anticoagulation therapy during subsequent pregnancies would override the bleeding and osteopenic risks associated with such therapy, said Dr. Ida Martinelli of the Istituto di Ricovero e Cura a Carattere Scientifico, Maggiore Hospital, Milan, and associates.
In their case-control study, 11 of 67 (16%) women with a first episode of unexplained late fetal loss and 13 of 232 (6%) control women with a history of only normal pregnancies had the prothrombin or factor V mutations (N. Engl. J. Med. 343[14]:1015-18, 2000).
The relative risk of late fetal loss in carriers of factor V or prothrombin mutations was 3.2 and 3.3, respectively, compared with ...
Source: HighBeam Research, Screen for Genetic Mutations In Women With a History Of Late...